Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Bupropion for the treatment of methamphetamine dependence.

Elkashef AM, Rawson RA, Anderson AL, Li SH, Holmes T, Smith EV, Chiang N, Kahn R, Vocci F, Ling W, Pearce VJ, McCann M, Campbell J, Gorodetzky C, Haning W, Carlton B, Mawhinney J, Weis D.

Neuropsychopharmacology. 2008 Apr;33(5):1162-70. Epub 2007 Jun 20.

2.

Smoked cocaine self-administration is decreased by modafinil.

Hart CL, Haney M, Vosburg SK, Rubin E, Foltin RW.

Neuropsychopharmacology. 2008 Mar;33(4):761-8. Epub 2007 Jun 13.

3.

A randomized, double-blind, crossover trial of modafinil on mood.

Taneja I, Haman K, Shelton RC, Robertson D.

J Clin Psychopharmacol. 2007 Feb;27(1):76-9.

PMID:
17224718
4.

Use of modafinil for the treatment of attention deficit/hyperactivity disorder.

Lindsay SE, Gudelsky GA, Heaton PC.

Ann Pharmacother. 2006 Oct;40(10):1829-33. Epub 2006 Sep 5. Review.

PMID:
16954326
5.

A 12-year follow-up of a treated cocaine-dependent sample.

Hser YI, Stark ME, Paredes A, Huang D, Anglin MD, Rawson R.

J Subst Abuse Treat. 2006 Apr;30(3):219-26.

PMID:
16616166
6.

Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior.

Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, Koob GF, de Lecea L.

Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19168-73. Epub 2005 Dec 15.

7.

Origins, issues and options in the development of the combined behavioral intervention.

Longabaugh R, Zweben A, Locastro JS, Miller WR.

J Stud Alcohol Suppl. 2005 Jul;(15):179-87; discussion 168-9.

PMID:
16223069
8.

Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers.

Donovan JL, DeVane CL, Malcolm RJ, Mojsiak J, Chiang CN, Elkashef A, Taylor RM.

Clin Pharmacokinet. 2005;44(7):753-65.

PMID:
15966757
9.

Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned.

Kampman KM, Leiderman D, Holmes T, LoCastro J, Bloch DA, Reid MS, Shoptaw S, Montgomery MA, Winhusen TM, Somoza EC, Ciraulo DA, Elkashef A, Vocci F.

Addiction. 2005 Mar;100 Suppl 1:102-10.

PMID:
15730354
10.

A double-blind, placebo-controlled trial of modafinil for cocaine dependence.

Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP.

Neuropsychopharmacology. 2005 Jan;30(1):205-11.

11.

A pilot trial of topiramate for the treatment of cocaine dependence.

Kampman KM, Pettinati H, Lynch KG, Dackis C, Sparkman T, Weigley C, O'Brien CP.

Drug Alcohol Depend. 2004 Sep 6;75(3):233-40.

PMID:
15283944
12.

Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder.

Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ.

Biol Psychiatry. 2004 May 15;55(10):1031-40.

PMID:
15121488
13.

Glutamate transmission and addiction to cocaine.

Kalivas PW, McFarland K, Bowers S, Szumlinski K, Xi ZX, Baker D.

Ann N Y Acad Sci. 2003 Nov;1003:169-75.

PMID:
14684444
14.

Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study.

Dackis CA, Lynch KG, Yu E, Samaha FF, Kampman KM, Cornish JW, Rowan A, Poole S, White L, O'Brien CP.

Drug Alcohol Depend. 2003 May 1;70(1):29-37.

PMID:
12681523
15.

Clinical applications of modafinil in stimulant abusers: low abuse potential.

Malcolm R, Book SW, Moak D, DeVane L, Czepowicz V.

Am J Addict. 2002 Summer;11(3):247-9. No abstract available.

PMID:
12202017
16.

Discriminative-stimulus effects of modafinil in cocaine-trained humans.

Rush CR, Kelly TH, Hays LR, Wooten AF.

Drug Alcohol Depend. 2002 Aug 1;67(3):311-22.

PMID:
12127202
17.

Hypothalamic arousal regions are activated during modafinil-induced wakefulness.

Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, Saper CB.

J Neurosci. 2000 Nov 15;20(22):8620-8.

18.
19.
20.

The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade.

Ferraro L, Antonelli T, Tanganelli S, O'Connor WT, Perez de la Mora M, Mendez-Franco J, Rambert FA, Fuxe K.

Neuropsychopharmacology. 1999 Apr;20(4):346-56.

Items per page

Supplemental Content

Write to the Help Desk